Up-regulation of PLK1 in some of the breast cancer subtypes may inhibit tumor development by interfering with cytokinesis and mitosis [92,93] as well as one of the NIMA kinases NEK9, which is associated with tumor growth prevention, when upregulated [94]. Here, PLK1 is linked to breast carcinoma.